Prevention: An aspirin a day keeps the CRC at bay in Lynch syndrome
Nature Reviews Clinical Oncology 12, 562 (2015).
doi:10.1038/nrclinonc.2015.148
Whether adiposity is a risk factor for the development of hereditary colorectal cancer (CRC) in patients with Lynch syndrome is unclear. In a prospective study, 937 patients were randomly assigned to receive daily aspirin (600 mg) or placebo. The CRC risk was greater in obese
Source: Nature Clinical Practice Oncology - Category: Cancer & Oncology Tags: Research Highlight Source Type: research
More News: Aspirin | Cancer | Cancer & Oncology | Colorectal Cancer | Eating Disorders & Weight Management | HNPCC | Lynch Syndrome | Obesity | Study